Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
2,991
Total Claims
$268K
Drug Cost
282
Beneficiaries
$949
Cost/Patient
Risk Score Breakdown 5/100
Score components are additive. Read full methodology
Peer Comparison vs. 13,124 General Surgery providers
-96%
Opioid rate vs peers
1.1% vs 30.2% avg
+276%
Cost per patient vs peers
$949 vs $253 avg
+211%
Brand preference vs peers
15.5% vs 5.0% avg
Opioid Prescribing
1.1%
Opioid Rate
33
Opioid Claims
$252
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 462 claims · $184K
Generic: 2,510 claims · $83K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 114 | $45K |
| Empagliflozin | 24 | $28K |
| Sitagliptin Phosphate | 42 | $16K |
| Linagliptin | 12 | $15K |
| Rivaroxaban | 28 | $7,405 |
| Ertapenem Sodium | 11 | $4,404 |
| Lipase/Protease/Amylase | 24 | $3,538 |
| Atorvastatin Calcium | 211 | $3,266 |
| Pantoprazole Sodium | 74 | $3,061 |
| Aripiprazole | 11 | $2,725 |
| Dexlansoprazole | 20 | $2,617 |
| Tamsulosin Hcl | 110 | $2,495 |
| Imipenem/Cilastatin Sodium | 16 | $2,415 |
| Megestrol Acetate | 11 | $1,703 |
| Amlodipine Besylate | 149 | $1,689 |
Prescribing Profile
Patient Profile
80
Avg Age
51%
Female
2.49
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About